The most common conditions

Title Effect Research Type Journal Year
THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study. positive humans Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2017
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis. positive humans European journal of pain (London, England) 2009
Cannabis; adverse effects from an oromucosal spray. SAFE humans British dental journal 2007
An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray. positive humans Therapeutics and clinical risk management 2016
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. positive humans Journal of neurology, neurosurgery, and psychiatry 2016
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. positive humans Multiple sclerosis (Houndmills, Basingstoke, England) 2004
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. positive humans Multiple sclerosis (Houndmills, Basingstoke, England) 2004
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity. positive humans International clinical psychopharmacology 2016
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms. positive humans European neurology 2016
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain. positive humans European neurology 2016
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients. positive humans Journal of clinical pharmacology 2016
Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study. positive humans European neurology 2015
Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity. positive humans European neurology 2014
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity. positive humans The International journal of neuroscience 2014